Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Clover Health Investments
CLOV
Clover Health Investments
Rising Costs And Regulation Will Erode Medicare Advantage Profitability
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
23 Aug 25
Updated
23 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$2.50
9.2% overvalued
intrinsic discount
23 Aug
US$2.73
Loading
1Y
-18.0%
7D
4.6%
Author's Valuation
US$2.5
9.2% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$2.5
9.2% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-527m
3b
2018
2020
2022
2024
2025
2026
2028
Revenue US$2.8b
Earnings US$151.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
17.71%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$151.35m
Earnings '28
x
11.02x
PE Ratio '28
=
US$1.67b
Market Cap '28
US$1.67b
Market Cap '28
/
548.30m
No. shares '28
=
US$3.04
Share Price '28
US$3.04
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$2.50
Fair Value '25
